In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity

Background Immunotherapies, driven by immune-mediated antitumorigenicity, offer the potential for significant improvements to the treatment of multiple cancer types. Identifying therapeutic strategies that bolster antitumor immunity while limiting immune suppression is critical to selecting treatmen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marie-Claude Bourgeois-Daigneault, Adrianne L Jenner, Tyler Cassidy, Katia Belaid, Morgan Craig
Formato: article
Lenguaje:EN
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://doaj.org/article/5f4f68d6770b4180ada4a0d95539be66
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!